Nabriva Therapeutics AG ADR buy klostergang
Start price
25.08.17
/
50%
?7.59
Target price
27.08.18
€15.64
Performance (%)
-67.54%
End price
27.08.18
€2.46
Summary
This prediction ended on 27.08.18 with a price of €2.46. The BUY prediction by klostergang for Nabriva Therapeutics AG ADR performed very badly with a performance of -67.54%. klostergang has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Nabriva Therapeutics AG ADR | - | - | - | - |
| iShares Core DAX® | -0.874% | 5.325% | 6.865% | 65.211% |
| iShares Nasdaq 100 | -0.381% | 1.979% | 25.696% | 90.325% |
| iShares Nikkei 225® | -1.676% | 1.952% | 41.443% | 80.623% |
| iShares S&P 500 | -0.655% | 2.069% | 21.405% | 70.737% |
Comments by klostergang for this prediction
In the thread Nabriva Therapeutics AG ADR diskutieren
klostergang stimmt der Outperform-Einschätzung der institutionellen Analysten zu
klostergang stimmt am 25.08.2017 der Outperform-Einschätzung der institutionellen Analysten mit dem Kursziel 17.34$ zu.
(Laufzeit überschritten)